News | November 18, 2009

PET Perfusion Reimbursement to Increase in 2010

November 18, 2009 – The Centers for Medicaid and Medicare Services (CMS) recently announced it will increase the reimbursement for positron emission tomography (PET) cardiac procedures in 2010.

The final published rule maintains the assignment of all cardiac PET CPT codes to APC 0307 – PET myocardial perfusion imaging, with an increase in the payment for APC 0307 from $1,156.87 in 2009 to $1,432.87 in 2010 – a 24 percent increase from 2009. CMS’s Hospital Outpatient Prospective Payment System (HOPPS) and the 2010 payment rates for procedures continue to package payment for PET radiopharmaceuticals with payment for the imaging procedure (i.e. the nuclear medicine procedure ambulatory payment classifications (APC) payment rate).

The increased reimbursement makes it more economically feasible for groups to adopt cardiac PET, said officials at Bracco Diagnostics Inc., which supplies PET radiotracers. The company said the increase, combined with the current worldwide shortage of the Mo-99 isotope used in SPECT imaging, have created more compelling reasons for physicians and hospitals to implement PET for myocardial perfusion imaging.

PET also offers unique advantages that can be especially beneficial for difficult-to-image patients, including females, those who are obese or require pharmacologic stress testing, and patients with multivessel disease or who have had an equivocal SPECT MPI study.

The final rule established by CMS will be effective for services on or after Jan. 1, 2010.

For more information: www.braccoimaging.com, www.cms.hhs.gov/HospitalOutpatientPPS/HORD/list.asp#TopOfPage

Related Content

Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...
Feature | PET Imaging | November 07, 2018 | By Greg Freiherr
Positron emission tomography (PET) is getting ready to venture outside oncology, cardiology and mainstream neurology....
Podcast | PET Imaging | November 07, 2018
PET is getting ready to venture outside oncology, cardiology and mainstream neurology.
PET Imaging Offers New Possibilities in Chronic Liver Disease Management

Hepatic 18F-FDG, 18F-FAC, and 18F-DFA accumulation are affected in a mouse model of autoimmune hepatitis. (A) Histochemical and immunohistochemical analyses of liver sections from vehicle- and ConA-treated mice. Scale bars represent 50 microns. Transverse PET/CT images (B) and quantification (C) of vehicle- and ConA-treated mice injected with 18F-FDG, 18F-FAC, and 18FDFA. Livers are outlined in a white dotted line. Quantification represents radiotracer accumulation in the liver normalized to a background organ. Image courtesy of Salas J.R., Chen B.Y., Wong A., et al.

News | PET Imaging | October 24, 2018
While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications....